Intrepid Capital Management Inc. acquired a new stake in Cerner Co. (NASDAQ:CERN) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 11,800 shares of the company’s stock, valued at approximately $865,000.
Other large investors have also recently modified their holdings of the company. Nelson Roberts Investment Advisors LLC bought a new stake in Cerner in the 1st quarter valued at about $25,000. Berman Capital Advisors LLC increased its stake in Cerner by 115.3% during the 2nd quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock valued at $27,000 after buying an additional 204 shares during the period. Advisory Alpha LLC acquired a new position in Cerner during the 1st quarter valued at about $28,000. Altshuler Shaham Ltd increased its stake in Cerner by 173.2% during the 2nd quarter. Altshuler Shaham Ltd now owns 388 shares of the company’s stock valued at $28,000 after buying an additional 246 shares during the period. Finally, Valeo Financial Advisors LLC acquired a new position in Cerner during the 2nd quarter valued at about $49,000. Hedge funds and other institutional investors own 83.22% of the company’s stock.
Shares of CERN opened at $68.03 on Friday. The firm’s 50 day moving average is $70.10 and its 200-day moving average is $67.02. The stock has a market capitalization of $21.65 billion, a P/E ratio of 30.78, a P/E/G ratio of 1.90 and a beta of 0.92. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.52 and a quick ratio of 2.50. Cerner Co. has a 12-month low of $48.78 and a 12-month high of $76.47.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 9th. Investors of record on Wednesday, September 25th will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 1.06%. The ex-dividend date is Tuesday, September 24th. Cerner’s dividend payout ratio is currently 32.58%.
Several equities analysts have commented on the stock. Cantor Fitzgerald raised their target price on shares of Cerner from $75.00 to $85.00 and gave the company an “overweight” rating in a research note on Monday, July 8th. Bank of America raised their target price on shares of Cerner from $70.00 to $77.00 and gave the company a “buy” rating in a research note on Tuesday, May 21st. Piper Jaffray Companies raised their target price on shares of Cerner from $74.00 to $80.00 and gave the company an “overweight” rating in a research note on Thursday, July 25th. KeyCorp reissued an “overweight” rating and set a $82.00 target price (up previously from $76.00) on shares of Cerner in a research note on Friday, August 16th. Finally, BidaskClub cut shares of Cerner from a “sell” rating to a “strong sell” rating in a research note on Friday, September 6th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have given a buy rating to the stock. Cerner has a consensus rating of “Buy” and a consensus target price of $74.73.
In other Cerner news, CFO Marc G. Naughton sold 24,110 shares of Cerner stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $67.58, for a total value of $1,629,353.80. Following the completion of the sale, the chief financial officer now directly owns 84,898 shares in the company, valued at $5,737,406.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP John Peterzalek sold 27,484 shares of Cerner stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $72.11, for a total transaction of $1,981,871.24. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 288,377 shares of company stock valued at $19,427,390. 0.75% of the stock is currently owned by corporate insiders.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Read More: What is a management fee?
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.